Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats

Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats

Pulmonary arterial hypertension is a severe respiratory disease characterized by pulmonary artery remodeling. RV dysfunction and dysregulated circulating metabolomics are associated with adverse outcomes in pulmonary arterial hypertension. We investigated effects of tadalafil and macitentan alone or...

Full description

Bibliographic Details
Main Authors:	Argen Mamazhakypov, Astrid Weiß, Sven Zukunft, Akylbek Sydykov, Baktybek Kojonazarov, Jochen Wilhelm, Christina Vroom, Aleksandar Petrovic, Djuro Kosanovic, Norbert Weissmann, Werner Seeger, Ingrid Fleming, Marc Iglarz, Friedrich Grimminger, Hossein A. Ghofrani, Soni S. Pullamsetti, Ralph T. Schermuly
Format:	Article
Language:	English
Published:	SAGE Publishing 2020-11-01
Series:	Pulmonary Circulation
Online Access:	https://doi.org/10.1177/2045894020947283

Similar Items

Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers
by: Akylbek Sydykov, et al.
Published: (2018-05-01)

Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice
by: Akylbek Sydykov, et al.
Published: (2020-11-01)

Pulmonary Hypertension in Acute and Chronic High Altitude Maladaptation Disorders
by: Akylbek Sydykov, et al.
Published: (2021-02-01)

Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension
by: Brandes Ralf P, et al.
Published: (2011-06-01)

<i>Yarsagumba</i> is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties
by: Himal Luitel, et al.
Published: (2020-03-01)

The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities.
by: Nancy S Saad, et al.
Published: (2016-01-01)

Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension
by: Swathi Veeroju, et al.
Published: (2021-02-01)

Circulating Apoptotic Signals During Acute and Chronic Exposure to High Altitude in Kyrgyz Population
by: Djuro Kosanovic, et al.
Published: (2019-02-01)

Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling.
by: Xia Tian, et al.
Published: (2011-04-01)

The Role of G Protein-Coupled Receptors in the Right Ventricle in Pulmonary Hypertension
by: Gayathri Viswanathan, et al.
Published: (2018-12-01)

Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic
by: Dénes Csonka, et al.
Published: (2021-10-01)

Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model
by: Argen Mamazhakypov, et al.
Published: (2021-08-01)

Influence of gender in monocrotaline and chronic hypoxia induced pulmonary hypertension in obese rats and mice
by: Balram Neupane, et al.
Published: (2020-06-01)

Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration
by: Weissmann Norbert, et al.
Published: (2005-11-01)

Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension
by: Dioma U. Udeoji, et al.
Published: (2013-02-01)

The soluble guanylate cyclase stimulator riociguat ameliorates pulmonary hypertension induced by hypoxia and SU5416 in rats.
by: Michaela Lang, et al.
Published: (2012-01-01)

Effect of p53 activation on experimental right ventricular hypertrophy.
by: Swathi Veeroju, et al.
Published: (2020-01-01)

IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension
by: Siladitta Biswas, et al.
Published: (2020-10-01)

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension
by: Djuro Kosanovic, et al.
Published: (2019-07-01)

Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
by: Piotr Sklepkiewicz, et al.
Published: (2011-04-01)

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
by: Astrid Weiss, et al.
Published: (2019-05-01)

Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?
by: Djuro Kosanovic, et al.
Published: (2017-01-01)

Detection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy
by: Schudt Christian, et al.
Published: (2005-07-01)

Dual ET/ET blockade with macitentan improves both vascular remodeling and angiogenesis in pulmonary arterial hypertension
by: Valerie Nadeau, et al.
Published: (2017-11-01)

Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
by: Ghofrani Hossein A, et al.
Published: (2010-05-01)

Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury
by: Pullamsetti Soni S, et al.
Published: (2008-12-01)

5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure
by: Wiebke Janssen, et al.
Published: (2015-01-01)

Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension
by: Mario Boehm, et al.
Published: (2018-03-01)

The Role of Transient Receptor Potential Channel 6 Channels in the Pulmonary Vasculature
by: Monika Malczyk, et al.
Published: (2017-06-01)

Macitentan for the treatment of pulmonary arterial hypertension
by: Kholdani CA, et al.
Published: (2014-11-01)

Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs
by: Schrör Karsten, et al.
Published: (2007-01-01)

Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors
by: Weissmann Norbert, et al.
Published: (2005-07-01)

Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis
by: Klepetko Walter, et al.
Published: (2010-10-01)

Right Ventricular Remodeling and Dysfunction in Obstructive Sleep Apnea: A Systematic Review of the Literature and Meta-Analysis
by: Abdirashit Maripov, et al.
Published: (2017-01-01)

Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats
by: Ghofrani Hossein A, et al.
Published: (2011-05-01)

Macitentan in the treatment of pulmonary hypertension in Gaucher's disease
by: Gokay Taylan, et al.
Published: (2020-01-01)

Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding
by: Nabham Rai, et al.
Published: (2018-01-01)

Response to: Comment on “Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding”
by: Nabham Rai, et al.
Published: (2018-01-01)

The use of Macitentan in Fontan circulation: a case report
by: Polyvios Demetriades, et al.
Published: (2017-05-01)

Pharmacoeconomic aspects of macitentan in the therapy of pulmonary arterial hypertension
by: O M Moisseeva, et al.
Published: (2017-03-01)